While IL-10 secretion was upregulated in IL1β-stimulated monocytes of AD/AIT patients after treatment with 1,25(OH)2D3 [IL-10IL1β vs IL1β/1,25(OH)2D3 p = 0.003], this enhancement was neither observed in T1D/AIT patients nor in HC (Figure 4B). This evidence concerns the gene IL10 and type 1 diabetes mellitus.